|
|
Volumn 41, Issue 2, 2000, Pages 192-194
|
|
Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ALANINE AMINOTRANSFERASE;
ANTIRETROVIRUS AGENT;
ASPARTATE AMINOTRANSFERASE;
BLOOD CLOTTING FACTOR 5;
CD4 ANTIGEN;
DIDANOSINE;
DNA DIRECTED DNA POLYMERASE;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
HEPATITIS DELTA ANTIGEN;
IMMUNOGLOBULIN M;
LAMIVUDINE;
NEVIRAPINE;
NUCLEOSIDE DERIVATIVE;
PROTHROMBIN;
RHODAMINE;
RNA DIRECTED DNA POLYMERASE;
STAVUDINE;
TRYPTOPHAN;
VIRUS ANTIBODY;
VIRUS ANTIGEN;
VIRUS DNA;
VIRUS RNA;
ZALCITABINE;
ZIDOVUDINE;
ADULT;
ARTICLE;
CASE REPORT;
CHRONIC HEPATITIS;
CLINICAL EXAMINATION;
COMORBIDITY;
CONTROLLED STUDY;
CYTOLYSIS;
DISEASE EXACERBATION;
DOSE RESPONSE;
DRUG RESISTANCE;
DRUG WITHDRAWAL;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HOSPITALIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NONHUMAN;
TREATMENT PLANNING;
VIRUS MUTANT;
VIRUS REACTIVATION;
VIRUS REPLICATION;
VIRUS STRAIN;
|
|
EID: 0033759835
PISSN: 01634453
EISSN: None
Source Type: Journal
DOI: 10.1053/jinf.2000.0724 Document Type: Article |
|
Times cited : (25)
|
|
References (5)
|
